Interim Consolidated Statements of Operations (Unaudited) (USD $) In Thousands, except Per Share data	3 Months Ended		9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010	Sep. 30, 2011	Sep. 30, 2010
Interim Consolidated Statements of Income [Abstract]
PATIENT REVENUES, net	$ 80,644	$ 72,996	$ 236,946	$ 214,640
EXPENSES:
Operating	61,871	58,534	182,470	170,324
Lease	5,737	5,661	17,178	16,899
Professional liability	4,610	1,684	7,382	4,095
General and administrative	7,185	4,954	19,363	14,719
Depreciation and amortization	1,636	1,453	4,757	4,301
Asset Impairment	344		344
Total expenses	81,383	72,286	231,494	210,338
OPERATING INCOME (LOSS)	(739)	710	5,452	4,302
OTHER INCOME (EXPENSE):
Interest expense, net	(683)	(413)	(1,716)	(1,224)
Debt retirement costs			(112)	(127)
TOTAL OTHER INCOME (EXPENSE):	(683)	(413)	(1,828)	(1,351)
INCOME (L0SS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	(1,422)	297	3,624	2,951
(PROVISION) BENEFIT FOR INCOME TAXES	549	(68)	(1,112)	(1,028)
NET INCOME (LOSS) FROM CONTINUING OPERATIONS	(873)	229	2,512	1,923
NET INCOME (LOSS) FROM DISCONTINUED OPERATIONS:
Operating income (loss), net of taxes of $(6) and $207, respectively		(9)	(10)	359
Loss on disposal, net of taxes of $0 and $(96), respectively				(177)
DISCONTINUED OPERATIONS		(9)	(10)	182
NET INCOME (LOSS)	(873)	220	2,502	2,105
PREFERRED STOCK DIVIDENDS	(86)	(86)	(258)	(258)
NET INCOME (LOSS) FOR COMMON STOCK	$ (959)	$ 134	$ 2,244	$ 1,847
Per common share - basic
Continuing operations	$ (0.17)	$ 0.02	$ 0.39	$ 0.29
Discontinued operations				$ 0.03
Total Per common share - basic	$ (0.17)	$ 0.02	$ 0.39	$ 0.32
Per common share - diluted
Continuing operations	$ (0.17)	$ 0.02	$ 0.38	$ 0.28
Discontinued operations				$ 0.03
Total Per common share - diluted	$ (0.17)	$ 0.02	$ 0.38	$ 0.31
COMMON STOCK DIVIDENDS DECLARED PER SHARE OF COMMON STOCK	$ 0.055	$ 0.055	$ 0.165	$ 0.16
WEIGHTED AVERAGE COMMON SHARES:
Basic	5,779	5,742	5,770	5,729
Diluted	5,779	5,813	5,915	5,868